Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Transplantation and Cellular Therapy|August 17, 2021
Feasibility and Efficacy of a Pharmacokinetics-Guided Busulfan Conditioning Regimen for Allogeneic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Adult Patients with Hematologic MalignanciesStefania Bramanti, Chiara De Philippis, Antonella Bartoli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 17, 2009
Allogeneic stem cell transplantation compared with chemotherapy for poor-risk Hodgkin lymphomaLuca Castagna, Barbara Sarina, Elisabetta Todisco, et al.
Cytotherapy|August 17, 2024
Late-onset relapsing neurotoxicity after Brexucabtagene autoleucel associated with high chimeric antigen receptor T cells in cerebrospinal fluidChiara De Philippis, Arianna Giacomel, Umberto Pensato, et al.
British Journal of Haematology|April 7, 2009
Predictive value of early 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) during salvage chemotherapy in relapsing/refractory Hodgkin lymphoma (HL) treated with high-dose chemotherapyLuca Castagna, Stefania Bramanti, Monica Balzarotti, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 19, 2018
A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical siblingBarbara Sarina, Jacopo Mariotti, Stefania Bramanti, et al.
Radiation Oncology (London, England)|April 17, 2015
In-vivo dosimetry with Gafchromic films for multi-isocentric VMAT irradiation of total marrow lymph-nodes: a feasibility studyPietro Mancosu, Pierina Navarria, Giacomo Reggiori, et al.
Journal of Clinical Medicine|November 27, 2024
A New Tool Supporting the Selection of the Best Hematopoietic Stem Cell Donor by Modelling Local Own Real-World DataRoberto Crocchiolo, Stefania Cacace, Giuseppe Milone, et al.
Transplantation and Cellular Therapy|April 15, 2021
Nonmyeloablative Conditioning Regimen Including Low-Dose Total Marrow/Lymphoid Irradiation Before Haploidentical Transplantation with Post-Transplantation Cyclophosphamide in Patients with Advanced Lymphoproliferative DiseasesBarbara Sarina, Pietro Mancosu, Pierina Navarria, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2014
Impact of cytomegalovirus replication and cytomegalovirus serostatus on the outcome of patients with B cell lymphoma after allogeneic stem cell transplantationJacopo Mariotti, Francesco Maura, Francesco Spina, et al.
Cancer Medicine|November 9, 2019
Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamideJacopo Mariotti, Daniela Taurino, Fabrizio Marino, et al.
Pageof 7